Lethal Neonatal Carnitine Palmitoyltransferase II Deficiency: An Unusual Presentation of a Rare Disorder

ABSTRACT

A term male newborn, appropriate for gestational age, developed hypothermia, severe cardiac dysrrhythmia, and nonoliguric hyperkalemia within 24 hours of birth. Despite the prenatal identification of cystic renal dysplasia without oligohydramnios, at birth, a solitary left leg vascular hemangioma and large palpable kidneys were the only anomalies. Gradually hypotonia, lethargy, and poor feeding developed and by 20 hours of age recurrent cardiac dysrrhythmias, myocardial dysfunction, and renal insufficiency with intermittent hyperkalemia were apparent. Episodes of apnea developed on day 7 followed by respiratory failure, recurrent cardiac dysrrhythmias, and death on day 12. Eventually laboratory and autopsy findings confirmed the diagnosis of lethal neonatal carnitine palmitoyltransferase II deficiency.

KEYWORD

Carnitine palmitoyltransferase ii - cardiac dysrrhythmia - hyperkalemia - cystic renal dysplasia - hemangioma - cerebral dysgenesis

REFERENCES

• 1 McGarry J D, Brown N F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.  Eur J Biochem . 1997;  244 1-14
• 2 Roe C R, Coates P M. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease New York: McGraw-Hill 1995: 1501-1535
• 3 Demaugre F, Bonnefont J P, Colonna M. et al . Infantile form of carnitine palmitoyl II deficiency with hepatomuscular symptoms and sudden death: physiopathological approach to carnitine palmitoyltransferase II deficiencies.  J Clin Invest . 1991;  87 859-864
• 4 Taroni F, Verdirio E, Garavaglia B. et al .Biochemical and molecular studies of carnitine palmitoyltransferase II deficiency with hepatocardiomyopathic presentation. In: Coates PM, Tanaka K, eds. New Developments in Fatty Acid Oxidation New York: Willey-Liss 1992: 521-531
• 5 Hug G, Bove K E, Soukup S. Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II.  N Engl J Med . 1991;  325 1862-1864
• 6 Pierce M R, Pridjian G, Morrison S, Pickoff A S. Fatal carnitine plmitoyltransferase II deficiency in a newborn: new phenotypic features.  Clin Pediatr . 1999;  38 13-20
• 7 Albers S, Marsden D, Quackenbush E, Stark A R, Levy H L, Irons M. Detection of neonatal carnitine plmitoyltransferase II deficiency by expanded newborn screening with tandem mass spectrometry Pediatrics .  2001;  107 e103
• 8 Demaugre F, Bonnefont J P, Mitchell G, Nguyen-Hoang N, Pelet A nna, Rimoldi M. et al . Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: Two distinct entities.  Pediatr Res . 1988;  308-311
• 9 Zinn A B, Zurcher V L, Kraus F. et al . Carnitine palmitoyltransferase II deficiency: a heritable cause of neonatal cardiomyopathy and dysgenesis of the kidney.  Pediatr Res . 1991;  29 73A
• 10 Witt D R, Theobald M, Santa-Maria M, Packman S, Townsend S, Sweetman L. et al . Carnitine palmitoyl transferase type 2 deficiency.  Am J Hum Genet . 1991;  49(Suppl 4) 109
• 11 Elpeleg O N, Hammerman C, Saada A, Shaag Avrahm, Golzand E, Hochner-Celinikier D, Berger I, Nadjari M. Antenatal presentation of carnitine palmitoyltransferase II deficiency.  Am J Med Genet . 2001;  102 183-187
• 12 Land J M, Mistry S, Squier W. et al .Neonatal carnitine palmitoyltransferase deficiency: a case with a muscular presentation. In: Coates PM, Tanaka K, eds. New Developments in Fatty Acid Oxidation New York: Willey-Liss 1992: 309-315
• 13 North K N, Hoppel C L, Girolami U D, Kozakewich H PW, Korson M S. Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys.  J Peds . 1995;  127 414-420
• 14 Bonnefont J P, Demaugre F, Buus C P. et al . Carnitine palmitoyltransferase deficiencies.  Mole Genet Metab . 1999;  68 424-440
• 15 Saudubray J M, Martin D, Lonlay P D. et al . Recognition and management of fatty oxidation defects: A series of 107 patients.  J Inher Metab Dis . 1999;  22 488-502
• 16 Guignard J P. The stressed neonatal kidney: From pathophysiology to clinical management of neonatal vasomotor nephropathy.  Pediatr Nephrol . 2000;  14 227-239
• 17 Robillard J E, Guillery E N, Petershack J A. Renal function during fetal life. In: Barratt TM, Avner ED, Harmon WE, eds. Pediatric Nephrology Baltimore: Lippincott Williams and Wilkins 1999: 21-37
• 18 William D E. Potassium transport in early development. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology Philadelphia, PA: Saunders WB 1992: 1261-1263
• 19 Bonnet D, Martin D, Lonlay P. et al . Arrythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.  Circulation . 1999;  100 2248-2253